Long-term efficacy and safety of Roux-en-Y gastric bypass and gastric;Efectividad y seguridad a largo plazo del bypass gástrico en "y" de Roux y de la banda gástrica: revisión sistemática

Nutricion Hospitalaria

Volumn 25, Issue 6, 2010, Pages 964-970

  Camberos Solis, R ^a,b,c   Jimenez Cruz A ^c,d   Bacardi Gascon M ^c,d   Culebras, J M ^e  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Facultad de Medicina y Psicología   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^d Facultad de Medicina y Piscología   (Mexico)

^e UNIVERSITY OF LEÓN   (Spain)

Author keywords

Bariatric surgery; Mortality; Obesity; Treatment; Weight loss

Indexed keywords

ADOLESCENT; ADULT; BARIATRIC SURGERY; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; MORBID OBESITY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ROUX Y ANASTOMOSIS; SAFETY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADOLESCENT; ADULT; ANASTOMOSIS, ROUX-EN-Y; BARIATRIC SURGERY; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAFETY; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 78649560263     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.6.4821     Document Type: Article

References (55)

1. Centers for Disease Control and Prevention (CDC). State-specific prevalence of obesity among adults-United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57: 765-8.
2. Berghöfer A, Pischon T, Reinhold T et al. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008; 8: 200.
3. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
4. Katzmarzyk PT, Mason C. Prevalence of class I, II and III obesity in Canada. CMAJ 2006; 174: 156-7.
5. Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore 2009; 38: 57-9.
6. OECD Health Data. http://www.ecosante.org/oecd.html. Accesadoel 13 de Octubre de 2009.
7. Artham SM, Lavie CJ, Milani RV, Ventura HO. The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases. Postgrad Med 2008; 120: 34-41.
8. Wilborn C, Beckham J, Campbell B et al. Obesity: prevalence, theories, medical consequences, management, and research directions. J Int Soc Sports Nutr 2005; 2: 4-31.
9. Pituelli Suárez N, Corbera Prin M, Lioi Luciani S et al. Prevalence of risk factors: obesity and lipid profile. An Pediatr (Barc) 2008; 68: 257-63.
10. Peytremann-Bridevaux I, Santos-Eggimann B. Health correlates of overweight and obesity in adults aged 50 years and over: results from the Survey of Health, Ageing and Retirement in Europe (SHARE). Obesity and health in Europeans aged > or = 50 years. Swiss Med Wkly 2008; 138: 261-6.
11. Guh DP, Zhang W, Bansback N et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
12. Rosa EC, Zanella MT, Ribeiro AB et al. Visceral obesity, hypertension and cardio-renal risk: a review. Arq Bras Endocrinol Metabol 2005; 49: 196-204.
13. Márquez-Ibáñez B, Armendáriz-Anguiano AL, Bacardí-Gascón M, Jiménez-Cruz A. Revisión de ensayos clínicos controlados mediante cambios en el comportamiento para el tratamiento de la obesidad. Nutr Hosp 2008; 23: 1-5.
14. Bacardí-Gascón M, Armendáriz-Anguiano AL, Jiménez-Cruz A. Tratamiento dietético de la obesidad. Nutrición Clínica 2008; 11: 18-24.
15. Lira-García C, Souto-Gallardo M, acardí-Gascón M, Jiménez-Cruz A. Revisión de la Efectividad de los Ingredientes de Productos Alternativos para la Pérdida de Peso. Rev Salud Pública (Bogota) 2008; 10: 818-830.
16. Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician 2004; 70: 1731-8.
17. Ness-Abramof R, Nabriski D, Apovian CM. Medical therapy for obesity: present and future. Isr Med Assoc J 2004; 6: 760-5.
18. Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007; 369: 71-7.
19. Rucker D, Padwal R, Li SK et al. Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007;335: 1194-1199.
20. Castañeda-González LM, Camberos-Solís R, Bacardí-Gascón M y Jiménez-Cruz A. Revisión sistemática de estudios clínicos aleatorios sobre el tratamiento farmacológico a largo plazo para la obesidad. Colombia Medica 2010; 41 (1): 17-25.
21. Bult MJ, Van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol 2008; 158: 135-45.
22. Sjöström L, Lindroos A-K, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
23. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond) 2008; 32: 93-7.
24. Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 2006; 91: 4223-31.
25. Brown W, Dixon JB, Brien PO. Management of obesity-the role of surgery. Aust Fam Physician 2006; 35: 584-6.
26. Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med 2006; 73: 993-1007.
27. Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes Care 2008; 2: 297-302.
28. Buchwald H. Consensus Conference Statement Bariatric surgery for morbid obesity: Health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis 2005; 1: 371-81.
29. Macdonald K. Overview of the epidemiology of obesity and the early history of procedures to remedy morbid obesity. Arch Surg 2003; 138: 357-360.
30. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005; 294: 1909-17.
31. Tice JA, Karliner L, Walsh J et al. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121: 885-93.
32. Blackburn GL. Solutions in weight control: lessons from gastric surgery. Am J Clin Nutr 2005; 82: 248S-252S.
33. Wilkinson LH, Peloso OA. Gastric (reservoir) reduction for morbid obesity. Arch Surg 1981; 116: 602-605.
34. Kuzmak LI. Silicone gastric banding: a simple an effective operation for morbid obesity. Contemp Surg 1986; 28: 13-18.
35. Broadbent R, Tracey M, Harrington P. Laparoscopic gastric banding: a preliminary report. Obes Surg 1993; 3: 63-67. (Pubitemid 23053426)
36. Grace DM. Gastric restriction procedures for treating severe obesity. Am J Clin Nutr 1992; 55: 556S-559S.
37. Rubenstein RB. Laparoscopic adjustable gastric banding at a U.S. center with up to 3-year follow-up. Obes Surg 2002; 12: 380-384.
38. Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am 1967; 47: 1345-1352.
39. Mason EE, Printen KJ, Hartford CE, Boyd WC. Optimizing results of gastric bypass. Ann Surg 1975; 182: 405-414.
40. Herron DM. The surgical management of severe obesity. Mt Sinai J Med 2004; 71: 63-71.
41. Fobi MA. Surgical treatment of obesity: a review. J Natl Med Assoc 2004; 96: 61-75.
42. Atkins D, Briss PA, Eccles M, Flottorp S, Guyatt GH, Harbour RT et al. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res 2005; 5 (1): 25.
43. Simonsen MK, Hundrup YA, Obel EB, Grønbæk M, Heitmann BL. Intentional weight loss and mortality among initially healthy men and women. Nutr Rev 2008; 66 (7): 375-386.
44. Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992; 215: 387-95.
45. Howard L, Malone M, Michalek A et al. Gastric Bypass and Vertical Banded Gastroplasty- a Prospective Randomized Comparison and 5-Year Follow-up. Obes Surg 1995; 5: 55-60.
46. Fobi MA, Lee H, Igwe D Jr et al. Prospective comparative evaluation of stapled versus transected silastic ring gastric bypass: 6-year follow-up. Obes Surg 2001; 11: 18-24.
47. Nilsell K, Thörne A, Sjöstedt S et al. Prospective randomized comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001; 167: 504-9.
48. Mathus-Vliegen EM, De Wit LT. Health-related quality of life after gastric banding. Br J Surg 2007; 94: 457-65.
49. Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis 2007; 3: 127-32.
50. Pinheiro JS, Schiavon CA, Pereira PB et al. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis 2008; 4: 521-5.
51. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741-52.
52. De Wit LT, Mathus-Vliegen L, Hey C et al. Open versus laparoscopic adjustable silicone gastric banding: a prospective randomized trial for treatment of morbid obesity. Ann Surg 1999; 230: 800-7.
53. Dulloo A. Supressed thermogenesis as a cause for resistance to slimming and obesity rebound: adaptation or illusion? Int J Obesity 2007; 31: 201-203.
54. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357 (8): 753-61.
55. O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006; 16 (8): 1032-40.